155 related articles for article (PubMed ID: 4808917)
1. Chemotherapy of thyroid cancer with adriamycin. Experience with 30 patients.
Gottlieb JA; Hill CS
N Engl J Med; 1974 Jan; 290(4):193-7. PubMed ID: 4808917
[No Abstract] [Full Text] [Related]
2. [Adriamycin cardiomyopathy].
Nilles M; Wehr M; Köhler F
Med Welt; 1984 Jan; 35(4):103-8. PubMed ID: 6700420
[No Abstract] [Full Text] [Related]
3. Adriamycin-a review.
Carter SK
J Natl Cancer Inst; 1975 Dec; 55(6):1265-74. PubMed ID: 1107570
[No Abstract] [Full Text] [Related]
4. Medullary carcinoma of the thyroid treated by low-dose adriamycin.
Porter AT; Ostrowski MJ
Br J Clin Pract; 1990 Nov; 44(11):517-8. PubMed ID: 2282316
[No Abstract] [Full Text] [Related]
5. [Failure of chemotherapoy in thyroid cancers (author's transl)].
Droz JP; Charbord P; Rougier P; Parmentier C
Bull Cancer; 1981; 68(4):350-2. PubMed ID: 7198496
[No Abstract] [Full Text] [Related]
6. [Results of chemotherapy in thyroid cancer].
Benker G; Reinwein D
Dtsch Med Wochenschr; 1983 Mar; 108(11):403-6. PubMed ID: 6186447
[TBL] [Abstract][Full Text] [Related]
7. [Diagnosis and therapy of undifferentiated thyroid neoplasms; chemotherapy].
Tsutsui K
Nihon Naika Gakkai Zasshi; 1997 Jul; 86(7):1196-201. PubMed ID: 9379099
[No Abstract] [Full Text] [Related]
8. Chemotherapy of thyroid carcinoma.
Ahuja S; Ernst H
J Endocrinol Invest; 1987 Jun; 10(3):303-10. PubMed ID: 3624802
[TBL] [Abstract][Full Text] [Related]
9. Melphalan versus adriamycin in the treatment of advanced carcinoma of the ovary.
de Palo GM; de Lena M; Di Re F; Luciani L; Valagussa P; Bonadonna G
Surg Gynecol Obstet; 1975 Dec; 141(6):899-902. PubMed ID: 1103333
[TBL] [Abstract][Full Text] [Related]
10. Adriamycin. A new anticancer drug with significant clinical activity.
Blum RH; Carter SK
Ann Intern Med; 1974 Feb; 80(2):249-59. PubMed ID: 4590654
[No Abstract] [Full Text] [Related]
11. Results of a clinical trial with intermittent doses of adriamycin in lung cancer.
Kenis Y; Michel J; Rimoldi R; Lévy P; Israël L
Eur J Cancer (1965); 1972 Oct; 8(5):485-9. PubMed ID: 4346865
[No Abstract] [Full Text] [Related]
12. [Chemotherapy for medullary cancer of the thyroid. Phase II trials with adriamycin and cis-platinum administered as monochemotherapy].
Droz JP; Rougier P; Goddefroy V; Schlumberger M; Gardet P; Parmentier C
Bull Cancer; 1984; 71(3):195-9. PubMed ID: 6541515
[TBL] [Abstract][Full Text] [Related]
13. Combination chemotherapy with adriamycin (NSC-123127) and 1-(2-chloroethyl)-3-cyclohexyl 1-nitrosourea (CCNU; NSC-79037).
Einhorn LH; Livingston RB; Gottlieb JA
Cancer Chemother Rep; 1973; 57(4):437-45. PubMed ID: 4586951
[No Abstract] [Full Text] [Related]
14. Failure of medullary carcinoma of the thyroid to respond to doxorubicin therapy.
Husain M; Alsever RN; Lock JP; George WF; Katz FH
Horm Res; 1978; 9(1):22-5. PubMed ID: 618781
[TBL] [Abstract][Full Text] [Related]
15. Chemoresponsiveness of Moloney sarcoma virus-induced osteosarcoma to adriamycin in the rat.
Olson HM; Capen CC
Cancer Res; 1978 Jun; 38(6):1561-7. PubMed ID: 274173
[No Abstract] [Full Text] [Related]
16. Hormone-induced regression of medullary (solid) thyroid carcinoma.
Wahner HW; Cuello C; Aljure F
Am J Med; 1968 Nov; 45(5):789-94. PubMed ID: 5687259
[No Abstract] [Full Text] [Related]
17. A partial response in anaplastic carcinoma of the thyroid with liposomal doxorubicin.
Moscetti L; Padalino D; Capomolla E; Nelli F; Pollera CF
J Exp Clin Cancer Res; 2005 Mar; 24(1):151-4. PubMed ID: 15943045
[TBL] [Abstract][Full Text] [Related]
18. Combination chemotherapy of metastatic thyroid cancer. Phase II study.
Bukowski RM; Brown L; Weick JK; Groppe CW; Purvis J
Am J Clin Oncol; 1983 Oct; 6(5):579-81. PubMed ID: 6193705
[TBL] [Abstract][Full Text] [Related]
19. Adriamycin therapy for advanced ovarian carcinoma recurrent after chemotherapy.
Hubbard SM; Barkes P; Young RC
Cancer Treat Rep; 1978 Sep; 62(9):1375-7. PubMed ID: 688281
[No Abstract] [Full Text] [Related]
20. Chemotherapy of thyroid cancer. An evaluation of experience with 37 patients.
Gottlieb JA; Hill CS; Ibanez ML; Clark RL
Cancer; 1972 Sep; 30(3):848-53. PubMed ID: 5075365
[No Abstract] [Full Text] [Related]
[Next] [New Search]
